Moderna Analyst Ratings
Wolfe Research Downgrades Moderna(MRNA.US) to Sell Rating, Cuts Target Price to $40
Deutsche Bank Adjusts Price Target on Moderna to $60 From $75, Keeps Hold Rating
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $60 to $112
Moderna Price Target Cut to $111.00/Share From $125.00 by Barclays
Moderna Is Maintained at Overweight by Barclays
BofA Securities Adjusts Price Target on Moderna to $90 From $110, Maintains Neutral Rating
A Quick Look at Today's Ratings for Moderna(MRNA.US), With a Forecast Between $55 to $111
Moderna Analyst Ratings
Brookline Capital Cuts Moderna's Price Target to $212 From $238
Moderna Is Maintained at Underweight by JP Morgan
Moderna Analyst Ratings
Evercore Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60
Moderna Stock Price Target Slashed. It's About Vaccines. -- Barrons.com
UBS Maintains Moderna(MRNA.US) With Buy Rating, Cuts Target Price to $108
Moderna Is Maintained at Buy by UBS
Moderna Analyst Ratings
Piper Sandler Maintains Moderna(MRNA.US) With Buy Rating, Maintains Target Price $115
TD Cowen Maintains Moderna(MRNA.US) With Hold Rating, Cuts Target Price to $60
Moderna Analyst Ratings